FAK activation is required for TNF-α-induced IL-6 production in myoblasts

Journal of Cellular Physiology

Volumn 223, Issue 2, 2010, Pages 389-396

  Tseng, Wen Pei ^a   Su, Chen Ming ^a   Tang, Chih Hsin ^b,c  

^a NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; FOCAL ADHESION KINASE; I KAPPA B; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PYRROLIDINE DITHIOCARBAMATE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FOCAL ADHESION KINASE 1; INTERLEUKIN-6; MICE; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOBLASTS; NF-KAPPA B; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950818780     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22047     Document Type: Article

References (32)

1. Angel P, Hattori K, Smeal T, Karin M. 1988. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55:875-885.
2. Argiles JM, Busquets S, Lopez-Soriano FJ. 2005. The pivotal role of cytokines in muscle wasting during cancer. Int J Biochem Cell Biol 37:2036-2046. (Pubitemid 41213293)
3. Baldwin AS Jr. 1996. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 14:649-683. (Pubitemid 26130197)
4. Balkwill F. 2009. Tumour necrosis factor and cancer. Nat Rev Cancer 9:361-371.
5. Brink M, Anwar A, Delafontaine P. 2002. Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia. Int J Cardiol 85:111-121; discussion 121-124.
6. Cary LA, Guan JL. 1999. Focal adhesion kinase in integrin-mediated signaling. Front Biosci 4:D102-D113.
7. Chan TO, Rittenhouse SE, Tsichlis PN. 1999. AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide- dependent phosphorylation. Annu Rev Biochem 68:965-1014. (Pubitemid 29449213)
8. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T. 1995. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 9:1586-1597.
9. Chen HC, Appeddu PA, Isoda H, Guan JL. 1996. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J Biol Chem 271:26329-26334. (Pubitemid 26347485)
10. Chen HC, Chan PC, Tang MJ, Cheng CH, Chang TJ. 1998. Tyrosine phosphorylation of focal adhesion kinase stimulated by hepatocyte growth factor leads to mitogen-activated protein kinase activation. J Biol Chem 273:25777-25782.
11. Cheung PF, Wong CK, Ip WK, Lam CW. 2008. FAK-mediated activation of ERK for eosinophil migration: A novel mechanism for infection-induced allergic inflammation. Int Immunol 20:353-363.
12. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. 1997. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388:548-554.
13. Garcia-Martinez C, Lopez-Soriano FJ, Argiles JM. 1993. Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem 125:11-18.
14. Goodman MN. 1991. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 260:E727-E730.
15. Graeve L, Baumann M, Heinrich PC. 1993. Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense. Clin Investig 71:664-671.
16. Grassl C, Luckow B, Schlondorff D, Dendorfer U. 1999. Transcriptional regulation of the interleukin-6 gene in mesangial cells. J Am Soc Nephrol 10:1466-1477.
17. Grimble RF. 1998. Nutritional modulation of cytokine biology. Nutrition 14:634-640.
18. Hatada EN, Krappmann D, Scheidereit C. 2000. NF-kappaB and the innate immune response. Curr Opin Immunol 12:52-58.
19. Huang WC, Chen JJ, Inoue H, Chen CC. 2003. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression. J Immunol 170:4767-4775.
20. Jones SA. 2005. Directing transition from innate to acquired immunity: Defining a role for IL- 6. J Immunol 175:3463-3468.
21. Lee CH, Shieh DC, Tzeng CY, Chen CP, Wang SP, Chiu YC, Huang CY, Hsu CJ, Fong YC, Tang CH. 2008. Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cdelta and NF-kappaB pathway in human synovial fibroblasts. Mol Immunol 45:3693-3702.
22. Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276:18934-18940.
23. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. 1993. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90: 10193-10197.
24. Mitch WE, Goldberg AL. 1996. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335:1897-1905.
25. Neff L, Zeisel M, Druet V, Takeda K, Klein JP, Sibilia J, Wachsmann D. 2003. ERK 1/2- and JNKs-dependent synthesis of interleukins 6 and 8 by fibroblast-like synoviocytes stimulated with protein I/II, a modulin from oral streptococci, requires focal adhesion kinase. J Biol Chem 278:27721-27728.
26. Plaisance S, Vanden Berghe W, Boone E, Fiers W, Haegeman G. 1997. Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol Cell Biol 17:3733-3743.
27. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. 1999. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274:30353-30356.
28. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD. 2000. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2:249-256.
29. Tan TW, Yang WH, Lin YT, Hsu SF, Li TM, Kao ST, Chen WC, Fong YC, Tang CH. 2009. Cyr61 increasesmigration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells. Carcinogenesis 30:258-268.
30. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S. 1995. I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 80:573-582.
31. Yokota K, Miyazaki T, Hirano M, Akiyama Y, Mimura T. 2006. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Rheumatol 33:463-471.
32. Zeisel MB, Druet VA, Sibilia J, Klein JP, Quesniaux V, Wachsmann D. 2005. Cross talk between MyD88 and focal adhesion kinase pathways. J Immunol 174:7393-7397.